WeVote

Bill

Bill

S 79

Requires that all special education students attending schools scheduled to be closed or to undergo a significant change be assigned to new schools prior to the implementation of the closing or change

2025 Regular Session Introduced by John Liu

Massachusetts bill expands medical cannabis eligibility by broadening the list of debilitating conditions (PTSD, opioid use disorder) and adding VA-documented veteran eligibility.

REFERRED TO EDUCATION
0
WeVote Research Nonpartisan
Bill Summary · S 79

Summary — S.79 (Senate Docket No. 979) — “An Act further defining eligibility for medical use marijuana”

Note on source materials and inconsistencies
- The materials provided contain conflicting metadata (an unrelated short title, multiple sponsors from different jurisdictions, and references to special-education/student reassignment and to New York). This summary focuses on the actual bill text included (Massachusetts Senate Docket No. 979 / Senate No. 79), which proposes amendments to chapter 94I of the Massachusetts General Laws governing medical-use cannabis eligibility.

Purpose and intent
- To revise and clarify the statutory definitions of “debilitating medical condition” and “qualifying patient” in Massachusetts’ medical marijuana law (chapter 94I, §1), thereby changing who may be certified and recognized as eligible for medical cannabis.

Key provisions (substantive changes)
1. Redefines “Debilitating medical condition” (replaces prior statutory definition) to explicitly include:
- cancer; glaucoma; positive status for HIV; AIDS; hepatitis C; amyotrophic lateral sclerosis (ALS); Crohn’s disease; Parkinson’s disease; multiple sclerosis; post‑traumatic stress disorder (PTSD); opioid use disorder;
- plus “other conditions as determined in writing by a registered qualifying patient’s registered healthcare professional.”
2. Revises the definition of “Qualifying patient” to provide two pathways:
- (1) any person diagnosed by a registered healthcare professional as having a debilitating medical condition (per the updated list); or
- (2) a veteran receiving health care at a federal Veterans Administration (VA) facility who provides documentation from the VA indicating a diagnosis of a debilitating medical condition.

Who would be affected
- Patients: Individuals with the enumerated conditions (including PTSD and opioid use disorder) and other conditions a treating registered healthcare professional documents in writing would be eligible to qualify under the statute.
- Veterans: Veterans who receive care at VA facilities — previously unclear or excluded in some state processes — would be able to qualify if they supply VA documentation showing a qualifying diagnosis.
- Healthcare professionals: Registered healthcare professionals would hold explicit authority to document additional qualifying conditions in writing.
- Regulated cannabis providers and regulators: The patient pool for medical cannabis programs could increase, affecting dispensary registrations, supply/demand planning, and program administration.

Procedural status and timeline (as provided)
- Introduced: January 13, 2025 (Senate)
- Referred: Committee on Cannabis Policy (and multiple committee references appear in the record)
- Senate action: Reported/advanced and PASSED SENATE (June 4, 2025); delivered to the House/Assembly and referred to Education.
- Hearing(s): Hearing originally scheduled and later rescheduled for July 22, 2025 (per provided entries).
- Note: The legislative action log contains duplicate and cross‑jurisdictional entries; confirm current status with the relevant legislative clerk or official online docket for final disposition.

Potential impacts and considerations
- Broadening explicit listed conditions (PTSD, opioid use disorder) and allowing clinician‑documented conditions may increase enrollment in the medical-use cannabis program.
- The VA‑documentation pathway may lower barriers for veterans served by federal facilities who otherwise face paperwork or eligibility ambiguities.
- Regulators will need to confirm how clinician-written determinations and VA documentation are verified and processed; implementing guidance or regulatory updates may be required.

Related materials
- The bill text references prior similar matters (e.g., House No. 4087 of 2023–2024). Given conflicting sponsor and jurisdictional metadata in the packet, consult the official Massachusetts legislative website or bill tracking services for authoritative bill text and status.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.